http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101788804-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
filingDate 2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101788804-B1
titleOfInvention Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate
abstract The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as an active ingredient and in particular to an extended release formulation made of granules containing an active ingredient in an inner core .
priorityDate 2008-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007141002-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451008030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10125936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9874960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409667724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46783703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9837243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2758875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571081
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21864285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44147317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14055602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9856063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452333222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426270916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425654805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408128213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493130

Total number of triples: 62.